{
    "nctId": "NCT00343616",
    "briefTitle": "Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98",
    "officialTitle": "Investigating Cognitive Function for Patients Participating in the BIG Trial 1-98 in Select Centers",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Cognitive/Functional Effects, Fatigue, Psychosocial Effects of Cancer and Its Treatment",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 135,
    "primaryOutcomeMeasure": "Objective cognitive function as measured by the CogState battery",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Enrolled in protocol IBCSG-1-98\n\n  * Must be in the fifth year of study treatment (i.e., still receiving tamoxifen or letrozole)\n* No breast cancer recurrence or second malignancy\n* Patients who received 2-4\u00bd years of tamoxifen and have chosen to switch to letrozole to complete 5 years of treatment on protocol IBCSG-1-98 are not eligible\n* Hormone receptor status\n\n  * Estrogen receptor- and/or progesterone receptor-positive tumor\n\nPATIENT CHARACTERISTICS:\n\n* Female\n* Postmenopausal\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics\n* No concurrent hormone replacement therapy",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}